Clinical Trials Logo

Filter by:
NCT ID: NCT00776347 Completed - Clinical trials for Dementia With Lewy Bodies (DLB)

Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)

Start date: October 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate change of cerebral glucose metabolism by donepezil therapy and to associate change of glucose metabolism and symptoms.

NCT ID: NCT00772538 Completed - Asthma Clinical Trials

Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)

Start date: October 2008
Phase: Phase 3
Study type: Interventional

The trial is a randomised, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of 5 µg tiotropium over a 48-week treatment period as compared to placebo. Tiotropium inhalation solution delivered by the Respimat® inhaler will be examined as add-on controller therapy on top of usual care in patients with severe persistent asthma. The primary objective of each trial is to evaluate the long term efficacy of tiotropium over placebo on top of usual care in patients with severe persistent asthma as determined by pulmonary function testing, effects on asthma exacerbations, effects on quality of life, on asthma control and health care resource utilisation. The secondary objective of each trial is to compare the long term safety of tiotropium with placebo in this patient population.

NCT ID: NCT00771394 Completed - Overactive Bladder Clinical Trials

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

Start date: October 2008
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy and safety of solifenacin succinate as add-on therapy for overactive bladder (OAB) symptoms in men who have been treated for benign prostatic hyperplasia (BPH) with tamsulosin hydrochloride for at least 6 weeks

NCT ID: NCT00771251 Completed - Clinical trials for Rheumatoid Arthritis

A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)

Start date: May 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of golimumab in patients with active rheumatoid arthritis despite DMARD (Disease-modifying antirheumatic drugs) therapy. Another objective is to evaluate the pharmacokinetics of golimumab.

NCT ID: NCT00770913 Completed - Clinical trials for Refractory Reflux Esophagitis

Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis

Start date: October 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of E3810 tablets in patients with Proton Pump Inhibitor-resistant reflux esophagitis.

NCT ID: NCT00770874 Completed - Cervical Cancer Clinical Trials

Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer

Start date: September 2008
Phase: Phase 3
Study type: Interventional

This study is an open-label, multicenter, multinational, two-arm, parallel randomized Phase 3 study evaluating the efficacy and safety of S-1+Cisplatin versus single-agent Cisplatin in patients with stage IVB, recurrent or persistent carcinoma of the cervix.

NCT ID: NCT00770692 Completed - Insomnia Clinical Trials

A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)

Start date: October 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the long-term safety of eszopiclone (2, 3 mg) in non-elderly patients with insomnia and eszopiclone (1, 2 mg) in elderly patients with insomnia.

NCT ID: NCT00770510 Completed - Primary Insomnia Clinical Trials

A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)

Start date: September 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to investigate and evaluate the efficacy of Eszopiclone in Japanese participants with primary insomnia.

NCT ID: NCT00769782 Completed - Metastatic Cancer Clinical Trials

Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

GISTs
Start date: October 2008
Phase: Phase 2
Study type: Interventional

RATIONALE: Surgery may be an effective treatment for liver metastasis from a gastrointestinal stromal tumor. PURPOSE: This phase II trial is studying how well surgery works in treating patients with liver metastasis from a gastrointestinal stromal tumor.

NCT ID: NCT00769496 Completed - Hyperphosphatemia Clinical Trials

BAY 77-1931 Long-term Extension From Phase II Study

Start date: January 2005
Phase: Phase 2
Study type: Interventional

A long-term study of BAY77-1931 (lanthanum carbonate) for hyperphosphatemia in patients undergoing hemodialysis